Navigation Links
ThermoGenesis Corp. To Announce Third Quarter Fiscal 2012 Results On May 10, 2012
Date:5/7/2012

RANCHO CORDOVA, Calif., May 7, 2012 /PRNewswire/ -- ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products that process and store adult stem cells, announced today it will report financial results for the fiscal third quarter ended March 31, 2012, on Thursday, May 10, 2012.

Company's Conference Call and Webcast

Management will host a conference call Thursday, May 10, 2012 at 2:00 PM Pacific (5:00 PM Eastern) to review the fiscal third quarter financial results. 

The call can be accessed by dialing 1-800-860-2442 within the U.S. or 1-412-858-4600 outside the U.S. and referencing, "ThermoGenesis." Mr. Matthew T. Plavan, Chief Executive Officer and Chief Financial Officer will host the call to discuss the third quarter results and other corporate events, followed by a Q&A session. Participants are asked to call the assigned number approximately five minutes before the conference call begins. 

To listen to the audio webcast of the call during or after the event, please visit: http://www.thermogenesis.com/investors-webcasts-and-calls.aspx.

Replay

A replay of the conference call will be available two hours after the call for the following five business days by dialing 1-877-344-7529 within the U.S. or 1-412-317-0088 outside the U.S. and entering the following account number when prompted '385107'.

About ThermoGenesis Corp.

ThermoGenesis Corp. (www.thermogenesis.com) is a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury.

This press release contains forward-looking statements.  These statements involve risks and uncertainties
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ThermoGenesis Announces AABB Accreditation for Cord Blood Products Customer in China
2. ThermoGenesis Announces Webcast of Presentation at Roth Capital Conference
3. ThermoGenesis Reports Second Quarter Fiscal 2012 Results
4. ThermoGenesis Provides Update on Res-Q® Clinical Evaluations at Leading Stem Cell Therapy Conference
5. Canadas First National Public Cord Blood Bank Adopts ThermoGenesis BioArchive Cryopreservation System
6. Thermogenesis Signs Worldwide Res-Q System Distribution Agreement With Arthrex for Sports Medicine Applications
7. ThermoGenesis Announces Webcast of Presentation at OneMedForum Conference
8. ThermoGenesis Corp. to Announce First Quarter Fiscal 2012 Results on November 10, 2011
9. ThermoGenesis Reports Fourth Quarter and Year End 2011 Results; Annual Net Loss Reduced by More Than 50 Percent
10. ThermoGenesis Presentation at Rodman & Renshaw Conference
11. ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... Lupin , Strides ... MPP Sub-licensees to Fourteen Companies     ... expansion of its network of generic manufacturers to 14 companies ... antiretrovirals (ARVs). New companies Lupin and Strides Arcolab recently signed ... the MPP licensed from ViiV Healthcare two months after its ...
(Date:7/1/2015)... July 1, 2015  Celsion Corporation (NASDAQ: CLSN ... Michael H. Tardugno , Chairman, President and CEO, ... Healthcare Conference on Wednesday, July 8, 2015, at 4:15 ... Parker Meridien Hotel located at 119 W. 56th Street, ... A copy of the presentation will be available ...
(Date:7/1/2015)... July 1, 2015 Egalet Corporation (Nasdaq: ... pharmaceutical company focused on developing, manufacturing and marketing ... Radie , president and chief executive officer, is ... He will provide an update on Egalet,s marketed ... Nasal Spray, approved product OXAYDO ™ (oxycodone ...
Breaking Medicine Technology:The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3
... First Totally Noninvasive Cardiovascular Monitor... -- AMSTERDAM, November 18, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
... 2010 Royal Philips Electronics (NYSE: PHG, AEX: ... of neonatal medical equipment, announced today that they ... a more complete portfolio of perinatal care solutions. ... home monitoring, neonatal incubators and warmers, jaundice management, ...
Cached Medicine Technology:BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States 2BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States 3BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States 4BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States 5BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States 6BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States 7BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States 8Philips and Atom Medical Corporation Announce Strategic Alliance to Provide a Complete Neonatal and Perinatal Offering 2Philips and Atom Medical Corporation Announce Strategic Alliance to Provide a Complete Neonatal and Perinatal Offering 3
(Date:7/1/2015)... ... July 01, 2015 , ... For decades, researchers in the genetics ... constant in the brain, never changing after development in the womb. Now, researchers from ... replaced in brain cells throughout life – a process which helps to switch genes ...
(Date:7/1/2015)... York, NY (PRWEB) , ... July 01, 2015 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – today announced that they will welcome four new members to their ...
(Date:7/1/2015)... ORANGE, Calif. (PRWEB) , ... July 01, 2015 ... ... advanced orthodontic technology and services, today announced that its fifth annual Smile for ... has raised $80,000 for the non-profit organization. In addition to supporting S4L in ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... a new extraction plant for Linablue®, Spirulina-derived natural blue food coloring. Construction of ... the DIC Group’s U.S. Spirulina* production base, began in May 2014. After commissioning, ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Collaborative for Children and Families ... Trust. The grant will allow CCF to improve quality of care and save costs ... formed to respond to many changes in New York’s Medicaid system. Experts agree that ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3
... Medifast, Inc.,(NYSE: MED ) today announced ... Eating and Weight Disorders, shows that individuals taking ... when they combine,their drug therapy with a medical ... study, conducted by researchers at the University of,Missouri-Kansas ...
... tool benefits physicians and their patients, ... high-quality,patient care, Independence Blue Cross (IBC) is ... IBC members with chronic,conditions. This summer, physicians ... with several important enhancements. The Registry is ...
... The Office - Are Raising Funds for the ... Lymphoma Research Foundation, ... opportunity to thank the many "employees" of the 48,branches of Dunder ... support during the DMI,s "Summer Splash - United Way,Fundraiser.", Under ...
... SmoothShapes(R) System in Kansas City Area, MERRIMACK, ... on body shaping, Eleme Medical Inc. announced today ... Kansas City plastic surgeon to offer the,SmoothShapes(R) system ... Leawood, Lee,s Summit and Northland Kansas City. Rajeunir,is ...
... towards collecting -- and analyzing -- data,designed to ... and HAMBURG, Germany, July 31 The,field of ... day.,And a new partnership with Washington,s largest biomedical ... is,contributing to that growth., Georgetown University Medical ...
... the levels of Epstein-Barr virus in children with liver transplants, ... recipients with detectable levels of the virus in their blood ... percent maintaining their response when they stopped taking the drug. ... Transplantation , a journal by John Wiley & Sons. The ...
Cached Medicine News:Health News:Medifast Program Combined with Appetite Suppressants Proven to Yield Double the Weight Loss Compared to Suppressants Alone 2Health News:Independence Blue Cross Enhances SMART(R) Registry 2Health News:Independence Blue Cross Enhances SMART(R) Registry 3Health News:Thank You, Dunder Mifflin Infinity 2Health News:New Anti-Cellulite Treatment Prepares Women for Warmer Weather and Beyond 2Health News:New Anti-Cellulite Treatment Prepares Women for Warmer Weather and Beyond 3Health News:Georgetown University Medical Center Collaborates with Indivumed to Develop Cancer Research Database 2Health News:Georgetown University Medical Center Collaborates with Indivumed to Develop Cancer Research Database 3Health News:Georgetown University Medical Center Collaborates with Indivumed to Develop Cancer Research Database 4Health News:Antiviral therapy helps children at risk for post-transplant lymphoproliferative disease 2
... complete imaging access, with nearly 100 percent ... imaging C-Arms can pan from head to ... patient. Anesthesiologists will appreciate this table for ... construction, and ease of operation. The key ...
...
LiquichekCardiac Markers Plus Control LT is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Medicine Products: